The National Organization for Rare Disorders (NORD)

Database Subscriptions

Many libraries, schools, universities, and hospitals subscribe to NORD’s Rare Disease Database for unlimited access to reports on more than 1,200 diseases.

Index of Rare Diseases

This is the list of diseases currently covered in the Rare Disease Database.

Rare Disease Database

Search this database for reports on more than 1,200 diseases.

View sample report

Index of Organizations

This is the list of organizations in NORD’s Organizational Database.

Organizational Database

Read about more than 2,000 patient organizations and other sources of help.

NORD's
Washington Office

Check here to read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.

 

News Briefs

CETT Increases Access to Genetic Tests

The Office of Rare Diseases of the National Institutes of Health has recently developed a new pilot program to help increase access to genetic tests for rare diseases. The Collaboration Education and Test Translation Program (CETT) is helping to make new genetic tests available to patients and families more quickly than was previously possible by encouraging the formation of collaborative teams that include a clinical laboratory, researcher, expert clinician and advocacy group for a particular rare disorder.

The mission of the CETT Program is to promote the development of new genetic tests for rare diseases; facilitate the translation of genetic tests from research laboratories to clinical practices; establish collaborations and provide education about each rare genetic disease, related genetic research and the clinical impact of testing; and support the collection and storage of genetic test result information in publicly accessible databases to leverage the information into new research and new treatment possibilities.

In the past year, ten new genetic tests for rare diseases have been made available to the public as a result of the CETT Program. The conditions that can now be tested for and the clinical laboratories providing testing are: Joubert syndrome (Prevention Genetics), Cornelia de Lange syndrome (University of Chicago), cherubism (Hospital for Sick Children Toronto), X-linked chondrodysplasia punctata (University of Chicago), Kallman syndrome (GeneDx), progressive familial intrahepatic cholestasis (Baylor College of Medicine), Russell Silver syndrome (Emory University) mucopolysaccharidosis type VI (Emory University), Niemann Pick disease type A/B (Emory University) and X-linked periventricular nodular heterotopia (Harvard University). Information about testing for these conditions is available at www.genetests.org.

Collaborative groups can apply to the CETT Program for funds to aid in the process of developing a new genetic test for a rare disease. For more information, please visit the CETT Program web site at www.cettprogram.org.

Over 1200 Disease Reports
Not a Subscriber yet?
                    Details Here

Enter your name and e-mail address if you would like to receive "News Blasts" from NORD






ABOUT | CONTACT NORD

Since 1983, working toward the prevention, treatment, and cure of rare “orphan” diseases.

Previous News Briefs

ICORD 2008

FDA and European Union Adopt Shared Form

NORD Representatives Address Congress

CETT Increases Access to Genetic Tests

NORD Honors Innovators at 2007 Tribute Banquet

Stay connected!

If you liked these News Briefs, you’ll love our free e-mail News Blasts. You’ll receive breaking news affecting the rare-disease community directly in your inbox if you enter your e-mail address in the box at the top of this page.

ABOUT NORD .|. CONTACT NORD .|. MEMBERSHIP .|. PRIVACY POLICY .|. DISCLAIMER .|. HOME
©2009 NORD - National Organization for Rare Disorders, Inc. All rights reserved.

Last modified Monday, June 02, 2008